EXAGEN INC. — Director's Dealing 2020

Mar 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2020-03-11

Reporting Person: PALLARES EBETUEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-11	Common Stock	M	22427	$1.84	Acquired	144094	Indirect
2020-03-11	Common Stock	F	2112	$19.507	Disposed	141982	Indirect
2020-03-11	Common Stock	M	2265	$1.84	Acquired	144247	Indirect
2020-03-11	Common Stock	F	214	$19.507	Disposed	144033	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-11	Warrants	$1.84	M	22427	Disposed		Common Stock (22427)	Indirect
2020-03-11	Warrants	$1.84	M	2265	Disposed		Common Stock (2265)	Indirect

Footnotes

F1: The shares reported on this form are held of record by PCM/Exagen, L.P. ("PCM"). Ebetuel Pallares is a co-manager of PCM. As a result, each of PCM and Dr. Pallares may be deemed to share beneficial ownership of the shares held of record by PCM.

F2: Represents the cashless net exercise of a warrant through the surrender of shares to the Issuer based on a fair market value of $19.507 per share, as determined by the average closing price of the Issuer's common stock for the ten trading days immediately preceding the date of exercise.

F3: The warrants are currently exercisable and will expire on January 19, 2026.

F4: The warrants are currently exercisable and will expire on March 31, 2026.